Mumbai: Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India.
Cipla's portable, wireless spirometer to ease diagnosis of COPD, asthma
Mumbai/IBNS: Indian multinational pharma giant Cipla Limited (BSE: 500087; NSE: CIPLA EQ) Wednesday announced the launch of Spirofy, India's first pneumotach based portable, wireless spirometer, on World COPD Day, the company said in a BSE filing.
Cinacalcet tablets case: Cipla, Amgen settle legal dispute
Mumbai/UNI: Pharma major, Cipla on Monday said company has settled a a legal dispute with Amgen in the United States involving generic cinacalcet hydrochloride tablets , used in treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease.